2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

The 2024 EULAR points to consider provide guidance on the management of targeted therapies in patients with IA and a previous malignancy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2024-12-20
DOI
https://doi.org/10.1136/ard-2024-225982
Citations
18
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
5.09
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Jeffrey R. Curtis, Katerina Chatzidionysiou, J. Molina Collada, Axel Finckh et al.
18 citations
PubMed
Cancer Immunotherapy and Biomarkers
5.09
article

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

Jeffrey R. Curtis, Katerina Chatzidionysiou, J. Molina Collada, Axel Finckh, Florenzo Iannone, Ertuğrul Çağrı Bölek, Zoltán Szekanecz, Johan Askling, Marie Kostine, Tore Kristian Kvien, Maya H Buch, Helena Canhão, François‐Xavier Danlos, Daniel Aletaha, Merete Lund Hetland, Heidi Bertheussen, Tue Wenzel Kragstrup, Anne C. Regierer, Vera Guimarães, Gerd R Burmester, Hendrik Schulze‐Koops, Karolina Gente, Samuel Bitoun, Kim Lauper, Lucía Silva-Fernández, E. Sebbag, Jacques‐Eric Gottenberg
article en
18 citations

Abstract

The 2024 EULAR points to consider provide guidance on the management of targeted therapies in patients with IA and a previous malignancy.

PubMed
University of Copenhagen (DK), University of Debrecen (HU), Harvard University (US), Aarhus University (DK), Heidelberg University (DE), University Hospital Heidelberg (DE), Karolinska Institutet (SE), University of Manchester (GB), Hospital General Universitario Gregorio Marañón (ES), University of Alabama at Birmingham (US), German Rheumatism Research Centre (DE), Regionshospitalet Silkeborg (DK), Diakonhjemmet Hospital (NO), Dana-Farber Cancer Institute (US), Complexo Hospitalario Universitario A Coruña (ES), Medical University of Vienna (AT), Charité - Universitätsmedizin Berlin (DE), Gazi University (TR)
Openalex Percentile: Top 3%
Cancer Immunotherapy and Biomarkers
5.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.